2,377
Views
2
CrossRef citations to date
0
Altmetric
Orphan Drugs

Value-based decision-making for orphan drugs with multiple criteria decision analysis: burosumab for the treatment of X-linked hypophosphatemia

, , , , , , & show all
Pages 1021-1030 | Received 26 Nov 2020, Accepted 14 Mar 2021, Published online: 01 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.